CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma

被引：0
|
作者：
Young Chang
Yun Bin Lee
Eun Ju Cho
Jeong-Hoon Lee
Su Jong Yu
Yoon Jun Kim
Jung-Hwan Yoon
机构：
[1] Department of Internal Medicine and Liver Research Institute,Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine
[2] Seoul National University College of Medicine,undefined
[3] Soonchunhyang University College of Medicine,undefined
来源：
BMC Cancer | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer
    Venkannagari, Sreedhar
    Fiskus, Warren
    Peth, Karissa
    Atadja, Peter
    Hidalgo, Manuel
    Maitra, Anirban
    Bhalla, Kapil N.
    ONCOTARGET, 2012, 3 (11) : 1416 - 1427
  • [32] Phase I dose escalation study of pan-histone deacetylase (HDAC) inhibitor abexinostat in combination with cisplatin in patients with advanced non-keratinizing nasopharyngeal carcinoma.
    Goh, Boon C.
    Hong, Ruey-Long
    Lim, Wan-Teck
    Cantero, Frederique
    Tan, Chee-Seng
    Robert, Renate
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Antibody-mediated blockade of annexin A3 (ANXA3) synergistically enhances the efficacy of sorafenib and regorafenib for hepatocellular carcinoma
    Tong, Man
    Che, Noelia
    Zhou, Lei
    Kau, Phillis W.
    Luk, Steve T.
    Chen, Xin
    Ding, Jin
    Lee, Terence K.
    Ma, Stephanie
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial
    O'Connor, Owen A.
    Masszi, Tamas
    Savage, Kerry J.
    Pinter-Brown, Lauren C.
    Foss, Francine M.
    Popplewell, Leslie
    Cashen, Amanda F.
    Doorduijn, Jeanette
    Chawla, Shanta
    Knoblauch, Poul
    Zinzani, Pier Luigi
    Brown, Peter
    Hess, Georg
    Van Hoof, Achiel
    Horwitz, Steven M.
    Shustov, Andrei R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Pre-Clinical Efficacy of Combined Therapy with LSD1 Antagonist SP-2509 and Pan-Histone Deacetylase Inhibitor Against AML Blast Progenitor Cells
    Fiskus, Warren
    Sharma, Sunil
    Abhyankar, Sunil
    McGuirk, Joseph
    Bearss, David J.
    Bhalla, Kapil
    BLOOD, 2012, 120 (21)
  • [36] Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells
    Youssef, Mohieldin M.
    Tolba, Mai F.
    Badawy, Noha N.
    Liu, Andrew W.
    El-Ahwany, Eman
    Khalifa, Amani E.
    Zada, Suher
    Abdel-Naim, Ashraf B.
    SCIENTIFIC REPORTS, 2016, 6
  • [37] Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells
    Mohieldin M. Youssef 
    Mai F. Tolba
    Noha N. Badawy
    Andrew W. Liu
    Eman El-Ahwany
    Amani E. Khalifa
    Suher Zada
    Ashraf B. Abdel-Naim
    Scientific Reports, 6
  • [38] Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
    Llopiz, Diana
    Ruiz, Marta
    Villanueva, Lorea
    Iglesias, Tamara
    Silva, Leyre
    Egea, Josune
    Lasarte, Juan J.
    Pivette, Perrine
    Trochon-Joseph, Veronique
    Vasseur, Berangere
    Dixon, Graham
    Sangro, Bruno
    Sarobe, Pablo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 379 - 393
  • [39] Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
    Diana Llopiz
    Marta Ruiz
    Lorea Villanueva
    Tamara Iglesias
    Leyre Silva
    Josune Egea
    Juan J. Lasarte
    Perrine Pivette
    Véronique Trochon-Joseph
    Bérangère Vasseur
    Graham Dixon
    Bruno Sangro
    Pablo Sarobe
    Cancer Immunology, Immunotherapy, 2019, 68 : 379 - 393
  • [40] A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy
    Wu, Bocheng
    Tapadar, Subhasish
    Ruan, Zhiping
    Sun, Carrie Q.
    Arnold, Rebecca S.
    Johnston, Alexis
    Olugbami, Jeremiah O.
    Arunsi, Uche
    Gaul, David A.
    Petros, John A.
    Kobayashi, Tatsuya
    Duda, Dan G.
    Oyelere, Adegboyega K.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (10) : 3155 - 3169
12345